基本信息
views: 319
Career Trajectory
Bio
Dr. William (Bill) Barry has devoted his career to clinical research and efforts to efficiently and rigorously test novel therapeutics and innovative strategies to improve health outcomes in a variety of disease settings.
Dr. Barry has more than 12 years of experience in Phase 1-3 clinical trials and translational research efforts to discover and validate genomic and proteomic signatures of diseases and molecular measures in response to interventions.
In 2010 while at the Institute for Genome Science and Policy at Duke University, Dr. Barry participated in a large federally-funded collaborative project in order to validate genomic signatures of the host response to the H1N1 virus and to evaluate the platform as a novel approach to diagnosis and detection of infection. At the Duke Cancer Institute and later at the Dana-Farber Cancer Institute, Dr. Barry supported multiple early-phase investigations into whether vaccines can be a novel and promising approach to targeted therapies as well as the enhancement of immune responses in breast cancer.
Rho’s cross-disciplinary and team-based approach to clinical research has been a strong motivator for Dr. Barry in a wide array of activities. Most recently, Dr. Barry participated in the design and conduct of trials for medical and infectious disease countermeasures under the Biomedical and Advanced Research Development Authority (BARDA).
Core Aims:
Provide biostatistical and computational biology expertise for the planning and design, conduct, analysis, and reporting of laboratory, genomic, animal, translational, clinical (including associated correlative studies), and epidemiological studies for SPORE Projects, Developmental Research and Career Development projects, and other SPORE Cores.
Provide consultation on all issues of data management and integrity, including data collection, storage, transfer and quality assurance, on statistical and computational biology software and programs, and on coordination of laboratory results with parameters and outcomes from clinical studies or clinical/translational research databases.
Provide short-term biostatistics and computational biology consulting to the entire group of SPORE researchers.
Dr. Barry has more than 12 years of experience in Phase 1-3 clinical trials and translational research efforts to discover and validate genomic and proteomic signatures of diseases and molecular measures in response to interventions.
In 2010 while at the Institute for Genome Science and Policy at Duke University, Dr. Barry participated in a large federally-funded collaborative project in order to validate genomic signatures of the host response to the H1N1 virus and to evaluate the platform as a novel approach to diagnosis and detection of infection. At the Duke Cancer Institute and later at the Dana-Farber Cancer Institute, Dr. Barry supported multiple early-phase investigations into whether vaccines can be a novel and promising approach to targeted therapies as well as the enhancement of immune responses in breast cancer.
Rho’s cross-disciplinary and team-based approach to clinical research has been a strong motivator for Dr. Barry in a wide array of activities. Most recently, Dr. Barry participated in the design and conduct of trials for medical and infectious disease countermeasures under the Biomedical and Advanced Research Development Authority (BARDA).
Core Aims:
Provide biostatistical and computational biology expertise for the planning and design, conduct, analysis, and reporting of laboratory, genomic, animal, translational, clinical (including associated correlative studies), and epidemiological studies for SPORE Projects, Developmental Research and Career Development projects, and other SPORE Cores.
Provide consultation on all issues of data management and integrity, including data collection, storage, transfer and quality assurance, on statistical and computational biology software and programs, and on coordination of laboratory results with parameters and outcomes from clinical studies or clinical/translational research databases.
Provide short-term biostatistics and computational biology consulting to the entire group of SPORE researchers.
Research Interests
Papers共 378 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gynecologic Oncology (2024): 105-112
crossref(2023)
crossref(2023)
CANCERno. 14 (2023): 2135-2143
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn